Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-05-17 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 275.8 KB | ||
| 2021-04-28 18:00 |
MISE À DISPOSITION DU DOCUMENT D'ENREGISTREMENT UNIVERSEL 2020
|
French | 232.3 KB | ||
| 2021-04-28 18:00 |
DOCUMENT D'ENREGISTREMENT UNIVERSEL 2020
|
French | 12.6 MB | ||
| 2021-04-28 16:12 |
URD AVRIL 2021
|
French | 12.6 MB | ||
| 2021-04-09 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 275.8 KB | ||
| 2021-04-07 18:00 |
RÉSULTATS ANNUELS 2020 ET POINT SUR L'AVANCEMENT DE SES PRINCIPAUX PROGRAMMES
|
French | 1.5 MB | ||
| 2021-04-07 18:00 |
2020 FULL-YEAR RESULTS AND UPDATE ON THE PROGRESS OF MAIN PROGRAMS
|
English | 1.4 MB | ||
| 2021-03-10 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 276.3 KB | ||
| 2021-03-09 18:00 |
THERANEXUS EXTENDS THE CAPABILITIES OF NEUROLEAD, ITS ACTIVE AGENT SCREENING PL…
|
English | 325.7 KB | ||
| 2021-03-09 18:00 |
THERANEXUS ÉTEND LES CAPACITÉS DE NEUROLEAD, SA PLATEFORME DE CRIBLAGE D'ACTIFS…
|
French | 351.3 KB | ||
| 2021-02-17 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 278.1 KB | ||
| 2021-01-27 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 275.2 KB | ||
| 2021-01-19 18:00 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 2nd SEMESTRE 2020
|
French | 594.7 KB | ||
| 2021-01-18 18:05 |
THERANEXUS PRESENTS AN UPDATE ON THE PROGRESS OF ITS MAIN PROGRAMS AND ANNOUNCE…
|
English | 537.5 KB | ||
| 2021-01-18 18:00 |
THERANEXUS FAIT UN POINT SUR l'AVANCEMENT DE SES PRINCIPAUX PROGRAMMES ET ANNON…
|
French | 493.1 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
